Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit J Arsenault

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Current Opinion in Lipidology|February 20, 2025
Leveraging drug-target Mendelian randomization for tailored lipoprotein-lipid loweringEloi Gagnon, Benoit J Arsenault
Atherosclerosis|March 28, 2024
Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases preventionEloi Gagnon, Benoit J Arsenault
Atherosclerosis|May 23, 2022
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspectiveBenoit J Arsenault, Pia R Kamstrup
Nature Reviews. Cardiology|September 5, 2012
HDL cholesterol is not HDL--don't judge the book by its coverBenoit J Arsenault, Jean-Pierre Després
Current Atherosclerosis Reports|November 26, 2013
Clinical and biological relevance of statin-mediated changes in HDL metabolismBenoit J Arsenault, S Matthijs Boekholdt
Clinical Pharmacology and Therapeutics|May 9, 2018
Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular DiseasesBenoit J Arsenault, Nicolas Perrot, Rishi Puri
Current Opinion in Lipidology|December 29, 2016
Does lifestyle contribute to disease severity in patients with inherited lipid disorders?Benoit J Arsenault, Nicolas Perrot, Patrick Couture
Cardiology|October 31, 2008
The quest for the optimal assessment of global cardiovascular risk: are traditional risk factors and metabolic syndrome partners in crime?Benoit J Arsenault, Philippe Pibarot, Jean-Pierre Després
Nutrients|June 14, 2017
Targeting Overconsumption of Sugar-Sweetened Beverages vs. Overall Poor Diet Quality for Cardiometabolic Diseases Risk Prevention: Place Your Bets!Benoit J Arsenault, Benoît Lamarche, Jean-Pierre Després
The Journal of Clinical Endocrinology and Metabolism|December 31, 2022
Body Fat Distribution, Fasting Insulin Levels, and Insulin Secretion: A Bidirectional Mendelian Randomization StudyEloi Gagnon, Patricia L Mitchell, Benoit J Arsenault
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Current Opinion in Lipidology|February 20, 2025
Leveraging drug-target Mendelian randomization for tailored lipoprotein-lipid loweringEloi Gagnon, Benoit J Arsenault
Atherosclerosis|March 28, 2024
Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases preventionEloi Gagnon, Benoit J Arsenault
Atherosclerosis|May 23, 2022
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspectiveBenoit J Arsenault, Pia R Kamstrup
Nature Reviews. Cardiology|September 5, 2012
HDL cholesterol is not HDL--don't judge the book by its coverBenoit J Arsenault, Jean-Pierre Després
Current Atherosclerosis Reports|November 26, 2013
Clinical and biological relevance of statin-mediated changes in HDL metabolismBenoit J Arsenault, S Matthijs Boekholdt
Clinical Pharmacology and Therapeutics|May 9, 2018
Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular DiseasesBenoit J Arsenault, Nicolas Perrot, Rishi Puri
Current Opinion in Lipidology|December 29, 2016
Does lifestyle contribute to disease severity in patients with inherited lipid disorders?Benoit J Arsenault, Nicolas Perrot, Patrick Couture
Cardiology|October 31, 2008
The quest for the optimal assessment of global cardiovascular risk: are traditional risk factors and metabolic syndrome partners in crime?Benoit J Arsenault, Philippe Pibarot, Jean-Pierre Després
Nutrients|June 14, 2017
Targeting Overconsumption of Sugar-Sweetened Beverages vs. Overall Poor Diet Quality for Cardiometabolic Diseases Risk Prevention: Place Your Bets!Benoit J Arsenault, Benoît Lamarche, Jean-Pierre Després
The Journal of Clinical Endocrinology and Metabolism|December 31, 2022
Body Fat Distribution, Fasting Insulin Levels, and Insulin Secretion: A Bidirectional Mendelian Randomization StudyEloi Gagnon, Patricia L Mitchell, Benoit J Arsenault
Pageof 16